Subgroup analysis revealed that high EZH2 expression might predict poor OS in NSCLC, endometrial carcinoma, and oral tongue carcinoma, as well as poor DFS in renal cell carcinoma. The gene discussed is EZH2; the disease is renal cell carcinoma.